No Data
No Data
Express News | Olema Pharmaceuticals Will Be Presenting Multiple Posters During The EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics (ENA 2024)
Express News | Olema Oncology Announces New Preclinical Combination Data to Be Presented at the 2024 Eortc-Nci-AACR Symposium on Molecular Targets and Cancer Therapeutics
Goldman Sachs Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Raises Target Price to $27
Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth
Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
Express News | JP Morgan Maintains Overweight on Olema Pharmaceuticals, Lowers Price Target to $31
No Data
No Data